Fast-growing companies in Uppsala’s life science cluster
During 2017, Uppsala BIO is updating its strategy for business establishment and growth. One part of this task is performing quantitative and qualitative studies to ensure that we take the right actions. We want to see organic growth in existing companies as well as new establishments.
We have therefore analyzed the life science sector in Uppsala, focusing on growth in small and medium-sized companies (10-250 employees), using data from the Swedish Companies Registration Office. In addition, we interviewed the CEO or other member of the management team of some twenty companies.
Between 2014 and 2015, the number of employees in this category increased by 11%. If we include 2013 as well, the increase is almost 20%. Furthermore, revenue increased by 11.5% between 2014 and 2015. It all sends out a strong signal – our region is home to some very viable companies!
Development in terms of employees in medium-sized companies 2013-2015
In our interviews we tried to identify the factors that affect a company’s future growth. One challenge mentioned by several is finding the finance to expand – to enter new geographic markets or develop additional product lines, for example. This need is in the range 50-200 MSEK – more than soft money offers but less than the lower limit of many investors. We have therefore met a number of investors to create interest in Uppsala’s life science and identify those interested in entering companies and supporting their growth. An initial meeting between a small group of investors and companies will be held this autumn and we look forward to the results. If all goes well, this should mean new knowledge, new contacts and, hopefully, new investments in Uppsala.
Want to know more? Don’t hesitate to contact me!
Director, Life Science Cluster Development
Scaling Up the Value: BioLamina
Uppsala BIO has an important role to connect and contribute to the overall growth of Life Sciences, nationally and internationally, both for academic institutions and companies.
Since the beginning of Testa Center, Uppsala BIOs team has as an external project coordinator role and has developed the application and selection process based on the BIO-X methodology.
Breaking down the numbers 2017-2018
The overall goal of Uppsala BIO is to contribute to Upsala's vision of 70,000 new jobs in 2050. Of these, at least 3500 jobs will be created in the life science sector.>>
Uppsala BIO helps Testa Center off to a flying start
Process based on successful BIO-X methodology.>>
“You can make a holding company profitable, but it takes a bit of luck.”
This autumn, Lars Jonsson, CEO of UU Holding since 1998, retires and hands over a very successful investment business to his successor. “UU Holding is nothing short of a success story,” writes Uppsala BIO’s Erik Forsberg. Lars Jonsson has proven that it is possible to make a holding company profitable.>>
Uppsala’s innovation support system works! Award-winning Kontigo Care is the latest proof.
“With its high costs and huge suffering for those affected as well as their relatives, alcohol abuse is one of our major social problems. Kontigo Care’s work on digital biomarkers is one of the most exciting things I’ve witnessed during my career,” writes Uppsala BIO Buiness Developer Magnus Engevik.>>
Spotlight Uppsala’s unique resource!
Uppsala’s life science industry is healthy and developing well. More than 100 life science companies can be found here and in 2016 they employed about 5000 people and had a combined turnover of approximately SEK 27 billion.>>
“What happens in Vegas stays in Vegas…”
During 52 hours, staff from the Academic Hospital, AbbVie, Bristol Myers-Squibb and Microsoft worked together to develop and test new ideas and models for early diagnosis and better treatment of cancer. Now the experiences of Sweden's first “Innovation Race” can be summed up.>>
50 years of excellence – it all started with a collaboration between academia and industry!
2017 marks the 50 year anniversary of the RAST-method. Learn about the history and see how Uppsala BIO and UU Innovation are addressing future challenges in asthma and allergy diagnostics.>>
Sweden needs new regulations and ways for collaboration to stay ahead in healthcare and the life sciences
Challenges and opportunities for countries wanting to take a leading role in life sciences, with focus on the future role of Sweden, was the topic of a seminar in May 2017. In our blog Johan Gómez de la Torre, Business Development Manager, Stockholm Science City digest the report.>>
Call for proposals: A pull to transform inventions into innovations
How do we pull out the good ideas that may become new innovative products or treatments for the benefit of patients? Calls for project proposals may be the pull that is needed.>>
Uppsala Health Summit 2017: Time for the world to meet on Infectious Disease Threats
10 – 11 October Uppsala Health Summit gathered 200 decision makers and experts from 30 different countries in a discussion about global threats from zoonotic infectious diseases.>>
EMA needs Sweden’s strong scientific environment
Karin Meyer, CEO, Swedish Pharmaceutical Society about what Sweden can offer the EMA and EU.>>
Check out EIT Health and its Uppsala activities
The purpose of EIT Health is to accelerate entrepreneurship and innovation for healthy living and active ageing in Europe.>>
Fast-growing companies in Uppsala’s life science cluster
Between 2014 and 2015, the number of employees in this category increased by 11%. If we include 2013 as well, the increase is almost 20%.>>
Financial support and further action!
Our long-term goal is, as always, to contribute to growth by driving actions that complement those of the private and public sectors.>>